
Kristin Gleitsman on Navigating Biology as a Living System
Chief Science Officer, Eigen Bio
Strategic insight for the builders of tomorrow’s biotech.
Live Last read · last published · next check

Chief Science Officer, Eigen Bio

Why strategic geometry determines whether you scale or stall.

Founder and Managing Partner, Phase Two Ventures

How strategic clarity determines access to capital, talent, and scale

How infrastructure shapes who gets to build, what gets funded, and which ideas survive

Co-Founder, Houser Labs

On listening to the people building the future of biotech today

On Infrastructure, Trust, and the Execution Gap

Toward a Theory of the Brave Biotech Brand

On the future of science and the meaning we build around it